I am not expecting any more speakers, and I reserve the balance of my time.

I want to make a special thanks to another staff person for the committee, Rachel Sher, who is on my right here, as well. Thank you, Rachel. I would now like to yield 3 minutes to the gentleman from Massachusetts (Mr. Markey).

I would like to yield 3 minutes to our chairman emeritus, Mr. Dingell, who has worked so hard and who has been so much a part of this legislation.

I just want to say in closing that I think it's a great example with this bill of what we can do, not only in the Energy and Commerce Committee but in general in this House, on a bipartisan basis when everyone works together for a common…

Today marks a very exceptional day in this body, one that deserves great praise. The bill before us, H.R. 5651, the FDA Reform Act of 2012, is the product of bipartisanship, collaboration, and compromise that I'm very proud of. The bill is…

Mr President, I rise in strong support of the underlying bill we are debating, the Food and Drug Administration Safety and Innovation Act. This legislation, which has been the model of bipartisanship and effective legislating on the part…

Mr. President, it is not the special interests that have caused the Senate countless times to reject this policy. It is an amendment that puts Americans at risk, undermines the FDA's authority, and would have a devastating ripple effect…

Madam President, I rise to speak against amendment No. 2107, the one that talks about pharmaceutical products, medicines. We know how important the prescription medicines are in improving health in this country and the need to make sure…

Madam President, I come to the floor today because we dare not stand here while a menace threatens children across our country with too many untested chemicals present in everyday consumer products, products intended for children's use…

Madam President, I ask unanimous consent the order for the quorum call be rescinded. The ACTING PRESIDENT pro tempore. Without objection, it is so ordered. Toxic Chemicals

Mr. President, I ask unanimous consent that the Committee on Finance be authorized to meet during the session of the Senate on May 23, 2012, at 10 a.m., in room SD 215 of the Dirksen Senate Office Building, to conduct a hearing entitled…

Mr. President, I ask unanimous consent that the Committee on Armed Services be authorized to meet during the session of the Senate on May 23, 2012, at 2:30 p.m. The PRESIDING OFFICER. Without objection, it is so ordered. Committee on…

Mr. President, I ask unanimous consent that the Subcommittee on Strategic Forces of the Committee on Armed Services be authorized to meet during the session of the Senate on May 23, 2012, at 9:30 a.m. The PRESIDING OFFICER. Without…

Mr. President, I ask unanimous consent that the Committee on Banking, Housing, and Urban Affairs Subcommittee on Security and International Trade and Finance be authorized to meet during the session of the Senate on May 23, 2012, at 2…

Mr. President, I ask unanimous consent that the Committee on the Judiciary, Subcommittee on Administrative Oversight and the Courts, be authorized to meet during the session of the Senate, on May 23, 2012, at 10 a.m., in room SD 226 of the…

Mr. President, I ask unanimous consent that the Committee on Veterans' Affairs be authorized to meet during the session on May 23, 2012, to conduct a hearing on ``Seamless Transition: Review of the Integrated Disability Evaluation…

Mr. President, I ask unanimous consent that the Committee on Homeland Security and Governmental Affairs be authorized to meet during the session of the Senate on May 23, 2012, at 10:30 a.m. to conduct a hearing entitled ``Secret Service on…

Mr. President, I ask unanimous consent that the Committee on Foreign Relations be authorized to meet during the session of the Senate on May 23, 2012, at 10 a.m., to hold a hearing entitled, ``The Law of the Sea Convention (Treaty Doc. 103…